Eargo 8 vs JLab Hear OTC

The Eargo 8 is a premium-priced OTC hearing aid ($2,399) that earns a B grade with a SoundScore of 3.3/5 in our lab testing. This invisible-in-ear device represents Eargo's 2025 flagship offering, featuring a rechargeable design that sits completely within the ear canal. In our testing, the Eargo 8 showed mixed performance across key metrics. Speech clarity in quiet environments is a relative strength, scoring 0.27 points above the OTC category average. Own-voice comfort also performs well, measuring 0.69 points above average at 3.2/5—a solid result that suggests reduced occlusion effects during conversation. However, speech understanding in noisy environments scored 1.2/5, which is both low in absolute terms and 0.27 points below the category average. The most significant limitation we measured was music streaming, which scored 0.0/5—nearly 2 points below the OTC average. This makes the Eargo 8 unsuitable for users who prioritize streaming audio quality. Feedback handling is strong in absolute terms at 4.2/5, though slightly below the category average. At its premium price point, the Eargo 8 faces stiff competition. Several devices in our database deliver comparable or better sound performance at lower prices, including alternatives from Eargo's own lineup. The Eargo 8 is best suited for users who prioritize invisible cosmetics and own-voice comfort over streaming capability and value, and who primarily need help hearing speech in quieter settings.

The JLab Hear OTC is a budget-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.5/5 in our lab testing. At $100, it represents one of the most affordable entry points into the OTC hearing aid market, ranking #36 of 65 devices in its category. This visible-in-ear device delivers a distinctive performance profile with clear strengths and weaknesses. Its standout feature is excellent music streaming quality, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during daily activities. These results suggest JLab leveraged its audio expertise from consumer earbuds in developing this product. However, speech clarity presents challenges. Speech in quiet scored 2.1/5 (0.67 points below category average), while speech in noise scored 1.0/5 (0.46 points below average). Own-voice comfort also measured low at 1.8/5. These limitations are significant for users prioritizing conversation clarity, which is typically the primary reason people seek hearing aids. The JLab Hear OTC is best suited for budget-conscious consumers who value music and media streaming alongside basic amplification, rather than those needing maximum speech intelligibility. Features include rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Buyers seeking stronger speech performance in this price range may want to compare options like the higher-scoring Elehear Beyond or Apple AirPods Pro 2.